Larry D Nichols
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1994First federal award
$6.1MFederal grants as PI30 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
30 awards · $6.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 19, 2002 | NIH | SBIR/STTR Phase II A New Method for Treating Sleep Disorders | $240K | — |
| Sep 19, 2002 | NIH | SBIR/STTR Phase II A New Method for Treating Sleep Disorders | $255K | — |
| Aug 1, 2002 | NIH | SBIR/STTR Phase II Transdermal Buprenorphine for Opiate Antagonist Therapy | $321K | — |
| Aug 1, 2002 | NIH | SBIR/STTR Phase I Transdermal Buprenorphine for Opiate Antagonist Therapy | $100K | — |
| Aug 1, 2000 | NIH | SBIR/STTR Phase I INJECTABLE CALCIUM SULFATE MICROSPHERES FOR PROTEINS | $100K | — |
| Apr 1, 2000 | NIH | NIH N43 A NEW METHOD FOR TREATING SLEEP DISORDERS | $100K | — |
| Mar 1, 2000 | NIH | SBIR/STTR Phase I VAGINAL BIOPROTECTION BY CONTROLLED ACIDIFICATION | $165K | — |
| Feb 1, 2000 | NIH | SBIR/STTR Phase I IMPLANTABLE BIODEGRADABLE CAPSULES FOR PROTEIN DELIVERY | $100K | — |
| Sep 28, 1999 | NIH | SBIR/STTR Phase II Transdermal Levonorgestrel for Emergency Contraception | $510K | — |
| Sep 28, 1999 | NIH | SBIR/STTR Phase I TRANSDERMAL LEVONORGESTREL FOR EMERGENCY CONTRACEPTION | $100K | — |
| Sep 28, 1999 | NIH | SBIR/STTR Phase II Transdermal Levonorgestrel for Emergency Contraception | $235K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase I ONE YEAR ESTROGEN/PROGESTIN IMPLANT | $100K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase II A One Year Estrogen/Progestin Implant | $448K | — |
| Sep 1, 1999 | NIH | SBIR/STTR Phase II A One Year Estrogen/Progestin Implant | $297K | — |
| Jul 1, 1999 | NIH | SBIR/STTR Phase II Vaginal Bioprotection by Controlled Acidification | $289K | — |
| Mar 1, 1999 | NIH | SBIR/STTR Phase I EPISODIC TRANSDERMAL DELIVERY FROM MELTABLE VEHICLES | $100K | — |
| Mar 1, 1999 | NIH | SBIR/STTR Phase I TRANSDERMAL PROSTAGLANDIN E1 TO TREAT MALE IMPOTENCE | $100K | — |
| Jul 15, 1998 | NIH | NIH N43 ABUSE RESISTANT TRANSDERMAL BUPRENORPHINE FOR OPIATE | $100K | — |
| Sep 30, 1996 | NIH | SBIR/STTR Phase I NEW BIODEGRADABLE POLYMERS BASED ON MANDELIC ACID | $100K | — |
| Sep 23, 1996 | NIH | SBIR/STTR Phase II A NEW SYNTHESIS OF BIODEGRADABLE POLYESTERS | $343K | — |
| Sep 23, 1996 | NIH | SBIR/STTR Phase I TIN FREE CATALYST FOR BIODEGRADABLE POLYESTERS | $100K | — |
| Sep 23, 1996 | NIH | SBIR/STTR Phase II A NEW SYNTHESIS OF BIODEGRADABLE POLYESTERS | $360K | — |
| Jun 13, 1996 | NIH | SBIR/STTR Phase I NEW METHOD FOR TREATING SLEEP DISORDERS IN THE AGED | $100K | — |
| Mar 1, 1996 | NIH | SBIR/STTR Phase II BIODEGRADABLE LEVONORGESTREL CONTRACEPTIVE IMPLANTS | $284K | — |
| Mar 1, 1996 | NIH | SBIR/STTR Phase II BIODEGRADABLE LEVONORGESTREL CONTRACEPTIVE IMPLANTS | $264K | — |
| Sep 10, 1995 | NIH | SBIR/STTR Phase II BIODEGRADABLE POLYACTIDE-CO-GLYCOLIDE MEDICAL CEMENTS | $394K | — |
| Sep 10, 1995 | NIH | SBIR/STTR Phase II BIODEGRADABLE POLYACTIDE CO GLYCOLIDE MEDICAL CEMENTS | $267K | — |
| Sep 10, 1995 | NIH | SBIR/STTR Phase I BIODEGRADABLE POLYLACTIDE-CO GLYCOLIDE MEDICAL CEMENTS | $100K | — |
| Apr 15, 1994 | NIH | SBIR/STTR Phase I BUPRENORPHINE FOR TRANSDERMAL ANALGESIA | $80K | — |
| 1994 | NIH | SBIR/STTR Phase I HYDROFORMED MICROSPHERES AS NEW INJECTABLE DRUG VEHICLE | $80K | — |
Peer ranks
Federal funding#43
Awards as PI#4
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.